Dr. Hoffman is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
5841 S Maryland Ave
Chicago, IL 60637Phone+1 888-824-0200Fax+1 773-702-0963
Education & Training
University of ChicagoFellowship, Hematology and Medical Oncology, 1977 - 1980
University of Pennsylvania Health SystemResidency, Internal Medicine, 1973 - 1975
Sidney Kimmel Medical College at Thomas Jefferson UniversityClass of 1972
Certifications & Licensure
IL State Medical License 1977 - 2026
FL State Medical License 2016 - 2021
PA State Medical License 1973 - 2006
GA State Medical License 1975 - 1987- American Board of Internal Medicine Internal Medicine
- American Board of Internal Medicine Hematology
- American Board of Internal Medicine Medical Oncology
Awards, Honors, & Recognition
- America's Top Doctors Castle Connolly, 2009-2014
- Chicago Magazine: Top Doctors Castle Connolly, 2006, 2008, 2010, 2012, 2014
- America's Top Doctors for Cancer Castle Connolly, 2005-2013
- Join now to see all
Clinical Trials
- S0002 - A Program to Quit Smoking With or Without Bupropion in Treating Patients With Stage I or II Non-Small Cell Lung Cancer Who Have Undergone Surgery Start of enrollment: 2002 Jan 01
- Dose Escalation of Bevacizumab With Ambulatory Blood Pressure Monitoring in Patients With Advanced Non-squamous NSCLC Start of enrollment: 2010 Mar 01
- Tamoxifen Citrate, Letrozole, Anastrozole, or Exemestane With or Without Chemotherapy in Treating Patients With Invasive RxPONDER Breast Cancer Start of enrollment: 2011 Jan 15
- Join now to see all
Publications & Presentations
PubMed
- 30 citationsA phase II study of 9-aminocamptothecin in advanced non-small-cell lung cancerEverett E. Vokes, R. H. Ansari, G. A. Masters, Philip C. Hoffman, A. Klepsch
Annals of Oncology. 1998-10-01 - 16 citationsA phase II trial of 9-aminocaptothecin (9-AC) as a 120-h infusion in patients with non-small cell lung cancer.Everett E. Vokes, Gary S. Gordon, Charles M. Rudin, Ann M. Mauer, S. Watson
Investigational New Drugs. 2001-01-01 - 43 citationsA Phase I Trial of Concurrent Or Sequential Ipilimumab, Nivolumab, and Stereotactic Body Radiotherapy in Patients with Stage IV Non-Small Cell Lung Cancer (COSINR Study)Christine M. Bestvina, K.B. Pointer, Theodore Karrison, Hania A. Al-Hallaq, Philip C. Hoffman
Journal of Thoracic Oncology. 2021-09-06
Press Mentions
'Started Getting a Little Squirrely': What We Heard This WeekFebruary 28th, 2020- First-Line Cyramza in NSCLC Gets Split Decision from FDA PanelFebruary 27th, 2020
- FDA Panel: Thumbs down for Prostate Cancer Focal TherapyFebruary 26th, 2020
- Join now to see all
Professional Memberships
- Member
- Member
- Member
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
